387167001: Orphenadrine citrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\...

\Glutamate receptor antagonist\NMDA receptor antagonist\Orphenadrine citrate (substance)

\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Orphenadrine citrate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Orphenadrine citrate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Antiparkinsonian agent (substance)\Orphenadrine citrate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Centrally acting muscle relaxant (substance)\Orphenadrine citrate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Substance with ether structure\Orphenadrine citrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461345016 Orphenadrine citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481275015 Orphenadrine citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4498251000005116 Orphenadrincitrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Orphenadrine citrate (substance)	Is a	Orphenadrine (substance)	false	Inferred relationship	Some
Orphenadrine citrate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Muscarinic receptor antagonist (disposition)	true	Inferred relationship	Some
Orphenadrine citrate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	N-methyl-D-aspartate receptor antagonist (disposition)	true	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	Centrally acting muscle relaxant (substance)	true	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	Antiparkinsonian agent (substance)	true	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	NMDA receptor antagonist	true	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	Muscarinic receptor antagonist	true	Inferred relationship	Some
Orphenadrine citrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Orphenadrine (substance)	true	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	Acetylcholine receptor antagonist	false	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	ether	false	Inferred relationship	Some
Orphenadrine citrate (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Orphenadrine citrate adverse reaction	Causative agent	True	Orphenadrine citrate (substance)	Inferred relationship	Some	1
allergi over for orphenadrincitrat	Causative agent	False	Orphenadrine citrate (substance)	Inferred relationship	Some
Orphenadrine citrate 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
orphenadrincitrat 30 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
orphenadrincitrat 100 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
paracetamol 500 mg + orphenadrincitrat 50 mg kapselformede tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
paracetamol + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
allergi over for orphenadrincitrat	Causative agent	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Orphenadrine citrate 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Orphenadrine citrate 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Orphenadrine citrate 100mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Orphenadrine citrate (substance)	Inferred relationship	Some
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Orphenadrine citrate 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Orphenadrine citrate (substance)	Inferred relationship	Some	1
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Orphenadrine citrate (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461345016	Orphenadrine citrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481275015	Orphenadrine citrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4498251000005116	Orphenadrincitrat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)